Okamura A - Search Results

1

Predictive factors for failure of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy in esophageal squamous cell carcinoma.

Terayama M, Okamura A, Oki A, Kuriyama K, Takahashi N, Tamura M, Kanamori J, Udagawa S, Shimozaki K, Osumi H, Fukuoka S, Ogura M, Chin K, Watanabe M. Terayama M, et al. Among authors: okamura a. Dis Esophagus. 2024 Dec 19:doae115. doi: 10.1093/dote/doae115. Online ahead of print. Dis Esophagus. 2024. PMID: 39696976

2

Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma.

Okamura A, Watanabe M, Mine S, Kurogochi T, Yamashita K, Hayami M, Imamura Y, Ogura M, Ichimura T, Takahari D, Chin K. Okamura A, et al. Dis Esophagus. 2017 Sep 1;30(9):1-8. doi: 10.1093/dote/dox075. Dis Esophagus. 2017. PMID: 28859367

3

Gastric conduit reconstruction after esophagectomy.

Watanabe M, Takahashi N, Tamura M, Terayama M, Kuriyama K, Okamura A, Kanamori J, Imamura Y. Watanabe M, et al. Among authors: okamura a. Dis Esophagus. 2024 Oct 2;37(10):doae045. doi: 10.1093/dote/doae045. Dis Esophagus. 2024. PMID: 38762331 Review.

4

[Perioperative Management Team in Esophageal Cancer Surgery].

Okamura A, Watanabe M. Okamura A, et al. Kyobu Geka. 2017 Jul;70(8):712-715. Kyobu Geka. 2017. PMID: 28790295 Review. Japanese.

5

Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.

Mine S, Watanabe M, Kumagai K, Okamura A, Yuda M, Hayami M, Yamashita K, Imamura Y, Ishizuka N. Mine S, et al. Among authors: okamura a. Dis Esophagus. 2019 Dec 30;32(11):doz002. doi: 10.1093/dote/doz002. Dis Esophagus. 2019. PMID: 30791046

6

Author's Reply: Significance of Intramural Metastasis in Patients with Esophageal Squamous Cell Carcinoma: An Indicator of Aggressive Cancer Behavior.

Okamura A, Watanabe M. Okamura A, et al. World J Surg. 2019 Oct;43(10):2649-2650. doi: 10.1007/s00268-019-05097-6. World J Surg. 2019. PMID: 31359077 No abstract available.

7

Salvage esophagectomy for initially unresectable locally advanced T4 esophageal squamous cell carcinoma.

Okamura A, Hayami M, Kozuki R, Takahashi K, Toihata T, Imamura Y, Mine S, Watanabe M. Okamura A, et al. Esophagus. 2020 Jan;17(1):59-66. doi: 10.1007/s10388-019-00700-0. Epub 2019 Oct 8. Esophagus. 2020. PMID: 31595397

8

Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma.

Suzuki T, Okamura A, Watanabe M, Mine S, Imamura Y, Asari T, Osumi H, Nakayama I, Ichimura T, Ogura M, Ooki A, Takahari D, Yamaguchi K, Chin K. Suzuki T, et al. Among authors: okamura a. Ann Surg Oncol. 2020 May;27(5):1510-1517. doi: 10.1245/s10434-019-08124-x. Epub 2019 Dec 9. Ann Surg Oncol. 2020. PMID: 31820213

9

ASO Author Reflections: How Should We Approach Borderline Resectable Esophageal Squamous Cell Carcinoma?

Suzuki T, Okamura A, Watanabe M, Chin K. Suzuki T, et al. Among authors: okamura a. Ann Surg Oncol. 2020 May;27(5):1518-1519. doi: 10.1245/s10434-020-08282-3. Epub 2020 Feb 27. Ann Surg Oncol. 2020. PMID: 32108921 No abstract available.

10

Clinical Significance of Pretherapeutic Serum Squamous Cell Carcinoma Antigen Level in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.

Okamura A, Matsuda S, Mayanagi S, Kanamori J, Imamura Y, Irino T, Kawakubo H, Mine S, Takeuchi H, Kitagawa Y, Watanabe M. Okamura A, et al. Ann Surg Oncol. 2021 Feb;28(2):1209-1216. doi: 10.1245/s10434-020-08716-y. Epub 2020 Jun 10. Ann Surg Oncol. 2021. PMID: 32524457

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

891 results

Search Page

Filters